Publication related to RSI or an RSI staff member

Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.

Authors

  • Taher, Mohamed Kadry, Taher MK, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Room 216, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada. Mohamed.Taher@uOttawa.ca.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada. Mohamed.Taher@uOttawa.ca.; Risk Sciences International, Ottawa, ON, Canada. Mohamed.Taher@uOttawa.ca.

  • Crispo, James A G, Crispo JAG, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Room 216, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Human Sciences Division, Northern Ontario School of Medicine, Sudbury, ON, Canada.

  • Fortin, Yannick, Fortin Y, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Room 216, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.; Statistics Canada, Ottawa, ON, Canada.

  • Moog, Ryan, Moog R, Cerner Corporation, Kansas City, MO, USA.

  • McNair, Douglas, McNair D, Melinda Gates Foundation, Seattle, WA, USA.

  • Bjerre, Lise M, Bjerre LM, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada.; Institut du Savoir Montfort, Ottawa, ON, Canada.

  • Momoli, Franco, Momoli F, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Ottawa, ON, Canada.; Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.

  • Mattison, Donald, Mattison D, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Room 216, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Ottawa, ON, Canada.

  • Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Room 216, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Risk Sciences International, Ottawa, ON, Canada.

YEAR OF PUBLICATION: 2022
SOURCE: Eur J Clin Pharmacol. 2022 Jun;78(6):1019-1028. doi: 10.1007/s00228-021-03260-4. Epub 2022 Mar 15.
JOURNAL TITLE ABBREVIATION: Eur J Clin Pharmacol
JOURNAL TITLE: European journal of clinical pharmacology
ISSN: 1432-1041 (Electronic) 0031-6970 (Print) 0031-6970 (Linking)
VOLUME: 78
ISSUE: 6
PAGES: 1019-1028
PLACE OF PUBLICATION: Germany
ABSTRACT:

BACKGROUND: Quinolones are popular antibiotics that are known for their potency, broad coverage, and reasonable safety. Concerns have been raised about a possible association between quinolones and retinal detachment (RD). METHODS: We conducted a nested case-control study using electronic health records (EHR) from the Health Facts(R) Database. The initial cohort included all patients who were admitted between 2000 and 2016, with no history of eye disease, and had a minimum medical history of one year. Eligible cases comprised inpatients who were first admitted with a primary diagnosis of RD between 2010 and 2015. Each eligible case was matched without replacement to five unique controls by sex, race, age, and period-at-risk. We used conditional logistic regression to calculate RD risk, adjusting for exposure to other medications, and major risk factors. RESULTS: We identified 772 cases and 3860 controls. Whereas our primary analysis of all subjects revealed no quinolone-associated RD risk, elevated but non-significant risks were noted in African Americans (ciprofloxacin and levofloxacin), those aged 56-70 years old (moxifloxacin), and women (ciprofloxacin). CONCLUSION: Our study did not identify an elevated RD risk within 30 days following systemic administration of quinolone antibiotics. Suggestions of increased risk observed in some population subgroups warrant further investigation.

COPYRIGHT INFORMATION: (c) 2022. The Author(s).
LANGUAGE: eng
DATE OF PUBLICATION: 2022 Jun
DATE OF ELECTRONIC PUBLICATION: 20220315
DATE COMPLETED: 20220517
DATE REVISED: 20220716
MESH DATE: 2022/05/18 06:00
EDAT: 2022/03/16 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1007/s00228-021-03260-4 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Donald Mattison

Chief Medical Officer, Senior Vice-President

Dr. Donald Mattison joined Risk Sciences International (RSI) in 2012 as Senior Vice-President and Chief Medical Officer, bringing with him a distinguished career spanning public health, clinical medicine, toxicology, and academic leadership. His appointment significantly strengthened RSI’s capacity to deliver...
Read More about Donald Mattison

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli